Antibody formulation in histidine-acetate buffer

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61K 47/18 (2006.01)

Patent

CA 2579861

The present application describes antibody formulations, including monoclonal antibodies formulated in histidine-acetate buffer, as well as a formulation comprising an antibody that binds to domain II of HER2 (for example, Pertuzumab), and a formulation comprising an antibody that binds to DR5 (for example, Apomab).

L'invention concerne des formulations d'anticorps, y compris des anticorps monoclonaux formulés dans un tampon d'histidine-acétate, ainsi qu'une formulation comprenant un anticorps qui se lie au domaine II de HER2 (par exemple le pertuzumab), et une formulation comprenant un anticorps qui se lie à DR5 (par exemple l'apomab).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antibody formulation in histidine-acetate buffer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibody formulation in histidine-acetate buffer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody formulation in histidine-acetate buffer will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1832969

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.